Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma

British Journal of Surgery

Volumn 100, Issue 11, 2013, Pages 1523-1530

  Harimoto, N ^a   Shirabe, K ^a   Yamashita, Y I ^a   Ikegami, T ^a   Yoshizumi, T ^a   Soejima, Y ^a   Ikeda, T ^a   Maehara, Y ^a   Nishie, A ^a   Yamanaka, T ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b National Cancer Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; RETROSPECTIVE STUDY; SARCOPENIA; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; BODY MASS INDEX; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SARCOPENIA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84883484836     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9258     Document Type: Article

References (30)

1. Llovet JM, Burroughs A, Bruix J,. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
2. Kiyosawa K, Tanaka E,. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62 (Suppl 1): 5-7.
3. Shirabe K, Takeishi K, Taketomi A, Uchiyama H, Kayashima H, Maehara Y,. Improvement of long-term outcomes in hepatitis C virus antibody-positive patients with hepatocellular carcinoma after hepatectomy in the modern era. World J Surg 2011; 35: 1072-1084.
4. Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, et al. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007; 205: 19-26.
5. Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita Y, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg 2007; 204: 580-587.
6. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K,. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14: 802-805.
7. Shimada M, Takenaka K, Fujiwara Y, Gion T, Shirabe K, Yanaga K, et al. Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma. Br J Surg 1998; 85: 195-198.
8. Aloia TA, Fahy BN, Fischer CP, Jones SL, Duchini A, Galati J, et al. Predicting poor outcome following hepatectomy: analysis of 2313 hepatectomies in the NSQIP database. HPB (Oxford) 2009; 11: 510-515.
9. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC,. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 6973-6979.
10. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN,. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012; 99: 550-557.
11. Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S,. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 2011; 18: 3579-3585.
12. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-173.
13. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, et al. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
14. Rosenberg I., Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989; 50: 1231-1233.
15. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al.; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
16. Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010; 210: 901-908.
17. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer (2nd English edn). Kanehara: Tokyo, 2003.
18. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
19. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
20. Yamashita Y, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, Shimada M, et al. Bile leakage after hepatic resection. Ann Surg 2001; 233: 45-50.
21. Rahbari NN, Koch M, Mehrabi A, Weidmann K, Motschall E, Kahlert C, et al. Portal triad clamping versus vascular exclusion for vascular control during hepatic resection: a systematic review and meta-analysis. J Gastrointest Surg 2009; 13: 558-568.
22. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996; 111: 720-726.
23. Royston P, Altman DG, Sauerbrei W,. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006; 25: 127-141.
24. Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005; 9: 1207-1215.
25. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al., Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
26. Baumgartner RN, Koehler KM, Romero L, Garry PJ,. Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 1996; 64: 552-558.
27. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629-635.
28. Pedersen BK, Febbraio MA,. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012; 8: 457-465.
29. Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, et al. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 2011; 29: 3892-3899.
30. Tsien CD, McCullough AJ, Dasarathy S,. Late evening snack: exploiting a period of anabolic opportunity in cirrhosis. J Gastroenterol Hepatol 2012; 27: 430-441.